Silviu Itescu
Oprichter bij MESOBLAST LIMITED
Vermogen: 51 M $ op 30-04-2024
Actieve functies van Silviu Itescu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MESOBLAST LIMITED | Directeur/Bestuurslid | 01-01-2007 | - |
| Algemeen Directeur | 23-03-2011 | - | |
| Oprichter | 08-06-2004 | - | |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Algemeen Directeur | 01-01-2004 | - |
| Oprichter | 01-01-2004 | - | |
| Columbia University Medical Center | Corporate Officer/Principal | 10-01-2011 | - |
Mesoblast UK Ltd.
 Mesoblast UK Ltd. Miscellaneous Commercial ServicesCommercial Services Mesoblast UK Ltd. engages in the provision of support services for the development of regenerative medicine products. The company was founded on April 7, 2011 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 07-04-2011 | - |
Loopbaan van Silviu Itescu
Eerdere bekende functies van Silviu Itescu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DIVERSA LIMITED | Directeur/Bestuurslid | - | 21-12-2006 |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | Corporate Officer/Principal | - | - |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | Corporate Officer/Principal | - | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
| Australië | 5 |
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MESOBLAST LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Health Technology |
Diversa Pty Ltd.
 Diversa Pty Ltd. Investment ManagersFinance Diversa Pty Ltd. engages in the provision of investment management and financial services. It operates through Superannuation Services and Trustee Services segments. The Superannuation Services segment provides administration and promotion services to superannuation funds and the issue of group risk products. The Trustee Services segment involves in the third party superannuation trustee services and investment services. The company was founded by Matthew Morgan and Angus Craig on July 03, 1997 and is headquartered in Melbourne, Australia. | Finance |
Mesoblast UK Ltd.
Mesoblast UK Ltd. Miscellaneous Commercial ServicesCommercial Services Mesoblast UK Ltd. engages in the provision of support services for the development of regenerative medicine products. The company was founded on April 7, 2011 and is headquartered in London, the United Kingdom. | Commercial Services |
- Beurs
- Insiders
- Silviu Itescu
- Ervaring
